With decades of leadership experience in the life science industry, our team fosters an ethos of innovation to develop regenerative medicine therapies aimed at treating a range of serious liver diseases. 

Keith Murphy

Executive Chairman

Thomas P. Hess

Chief Financial Officer

Curtis Tyree, Ph.D.

Senior Vice President, Strategy and Business Development